Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Status:
Unknown status
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of Radiotherapy plus
Endostar(Recombinant Human Endostatin) in patients with Pediatric Neuroblastoma.
Phase:
Phase 2
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine